These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1566 related items for PubMed ID: 30799537

  • 1. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F, Wang Y, Li C, Ma Y, Zhang Y, Li Z, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May 25; 21(5):529-534. PubMed ID: 29774934
    [Abstract] [Full Text] [Related]

  • 3. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S, Liu H, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb 25; 21(2):180-184. PubMed ID: 29492917
    [Abstract] [Full Text] [Related]

  • 5. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 6. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
    Han WX, Chen ZM, Wei ZJ, Xu AM.
    World J Surg Oncol; 2016 Nov 03; 14(1):279. PubMed ID: 27809860
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C, Yang W, Li N, Zhang Z, Hua Y, Liu H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):172-179. PubMed ID: 30799540
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J, Peng J, Fan W, Zhang R, Wang F, Zhou W, Xu D, Pan Z, Lu Z.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan 25; 22(1):73-78. PubMed ID: 30703797
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
    Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q, Wei SJ.
    World J Gastroenterol; 2015 Sep 14; 21(34):9999-10007. PubMed ID: 26379405
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D, Xu H, Huang J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb 25; 20(2):190-194. PubMed ID: 28226354
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD, Luo ZL, Fu MY, Tian D, Zhang L, Zhang KP.
    Zhonghua Zhong Liu Za Zhi; 2014 Dec 23; 36(12):916-21. PubMed ID: 25623766
    [Abstract] [Full Text] [Related]

  • 12. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D, Cao S, Tan X, Liu S, Liu X, Niu Z, Chen D, Wang D, Zhang J, Lv L, Li Y, Jiang H, Guo D, Li Y, Li Z, Zhou Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):156-163. PubMed ID: 30799538
    [Abstract] [Full Text] [Related]

  • 13. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P, Ma G, Liu Y, Ke B, Liu HM, Liang H, Zhang RP.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan 25; 27(1):54-62. PubMed ID: 38262901
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y, Xi H, Xie T, Qiu Z, Wang X, Wei B, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):143-148. PubMed ID: 30799536
    [Abstract] [Full Text] [Related]

  • 15. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H, Chen C, Yue J, Ma M, Ma Z, Yu Z.
    Zhonghua Zhong Liu Za Zhi; 2014 Feb 25; 36(2):141-6. PubMed ID: 24796465
    [Abstract] [Full Text] [Related]

  • 16. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD, Zhang H, Dong L, Jiang KW, Ye YJ, Wang S, Zhou J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):145-152. PubMed ID: 33508920
    [Abstract] [Full Text] [Related]

  • 17. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
    Lin JX, Wu D, Jiang YM, Chen JY, Lin GT, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Zheng CH, Huang CM.
    Zhonghua Wai Ke Za Zhi; 2022 Sep 01; 60(9):853-859. PubMed ID: 36058712
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M, Yamashita H, Watanabe T, Seto Y.
    World J Surg; 2018 Jan 01; 42(1):185-194. PubMed ID: 28741195
    [Abstract] [Full Text] [Related]

  • 19. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S, Habermehl D, Agha A, Belka C, Combs SE, Eckel R, Friess H, Gerbes A, Nüssler NC, Schepp W, Schmid RM, Schmitt W, Schubert-Fritschle G, Weber B, Werner J, Engel J.
    Strahlenther Onkol; 2018 Feb 01; 194(2):125-135. PubMed ID: 29071366
    [Abstract] [Full Text] [Related]

  • 20. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH.
    Medicine (Baltimore); 2016 May 01; 95(21):e3473. PubMed ID: 27227913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.